Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab

Clinical trial NCT07426913 · RECRUITING

Trial details

NCT number: NCT07426913
Sponsor: Virginia Commonwealth University
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Breast Cancer Anthracycline Related Cardiotoxicity in Breast Cancer Virtual Reality Trastuzumab

Start date: 2026-05-20
Primary completion: 2026-07-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.